Rosalind Advisors’s Grace Therapeutics GRCE Stock Holding History
Bought
Maintained
Sold
Other funds holding GRCE
OM
Rosalind Advisors's GRCE Position: Q3 2026 in Review
Rosalind Advisors opened a new position in Grace Therapeutics (GRCE) in Q3 2026: 476,190 shares worth $1.02M. The stake represents 0.33% of the portfolio and ranks #33 among its holdings.
38 funds tracked by Wall St. Rank hold GRCE as of Q3 2026.
- Rosalind Advisors held 476,190 shares of Grace Therapeutics worth $1.02M as of Q3 2026.
- Grace Therapeutics was a new Rosalind Advisors position in Q3 2026.
- Grace Therapeutics made up 0.33% of Rosalind Advisors's portfolio in Q3 2026, its #33 holding.
- 38 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2026.
Based on Rosalind Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.